FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

3855211000001104: Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25681301000001116 Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
25681401000001112 Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Is a Generic Pyrogastrone chewable tablets sugar free 100 tablet true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Is pack of Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) false Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has active ingredient Magnesium trisilicate false Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has active ingredient Sodium bicarbonate false Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has active ingredient Carbenoxolone sodium false Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has active ingredient Aluminium hydroxide dried false Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets VMP prescribing status (attribute) Never valid to prescribe as a VMP true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has manufactured dose form Conventional release chewable tablet false Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has AMP Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has specific active ingredient Magnesium trisilicate true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has specific active ingredient Aluminium hydroxide dried true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has specific active ingredient Carbenoxolone sodium true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has specific active ingredient Sodium bicarbonate true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier
Pyrogastrone chewable tablets (Sanofi-Synthelabo Ltd) 100 tablet 4 x 25 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start